Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 313


Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease.

Murray PG, Flavell JR, Baumforth KR, Toomey SM, Lowe D, Crocker J, Ambinder RF, Young LS.

J Pathol. 2001 Jun;194(2):158-64.


TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies.

Zapata JM, Krajewska M, Krajewski S, Kitada S, Welsh K, Monks A, McCloskey N, Gordon J, Kipps TJ, Gascoyne RD, Shabaik A, Reed JC.

J Immunol. 2000 Nov 1;165(9):5084-96.


TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.

Guo F, Sun A, Wang W, He J, Hou J, Zhou P, Chen Z.

Mol Immunol. 2009 Aug;46(13):2441-8. doi: 10.1016/j.molimm.2009.05.178.


Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW.

Blood. 2002 Jan 15;99(2):618-26.


Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.

Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF.

Oncogene. 1999 Nov 25;18(50):7161-7.


Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.

Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME, Watanabe T.

Oncogene. 2002 Apr 11;21(16):2493-503.


Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.

Knecht H, McQuain C, Martin J, Rothenberger S, Drexler HG, Berger C, Bachmann E, Kittler EL, Odermatt BF, Quesenberry PJ.

Oncogene. 1996 Sep 5;13(5):947-53.


The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y.

J Biol Chem. 1998 Oct 23;273(43):28355-9.


Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.

Fotin-Mleczek M, Henkler F, Hausser A, Glauner H, Samel D, Graness A, Scheurich P, Mauri D, Wajant H.

J Biol Chem. 2004 Jan 2;279(1):677-85.


High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

Pullen SS, Labadia ME, Ingraham RH, McWhirter SM, Everdeen DS, Alber T, Crute JJ, Kehry MR.

Biochemistry. 1999 Aug 3;38(31):10168-77.


Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.

Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H, Dörken B.

Blood. 1999 Nov 1;94(9):3129-34.


High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.

Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dörken B.

Blood. 1996 May 15;87(10):4340-7.


Expression of TNF-receptor-associated factor genes in murine tooth development.

Ohazama A, Courtney JM, Sharpe PT.

Gene Expr Patterns. 2003 May;3(2):127-9.


Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.

Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S, Dörken B, Zenke M, Stein H, Scheidereit C.

J Exp Med. 2002 Sep 2;196(5):605-17.


Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.

Herbst H, Samol J, Foss HD, Raff T, Niedobitek G.

J Pathol. 1997 Jul;182(3):299-306.

Items per page

Supplemental Content

Support Center